Table 1.
Noninvasive ventilation rate and application across included countries
| Country | Number of patients | Number of patients using NIV | NIV rate % (95% CI) |
NIV application | |
|---|---|---|---|---|---|
| Primary NIV | Post-extubation NIV | ||||
| Austria | 40 | 10 |
25.0% (12.7–41.2%) |
9 (90.0) | 1 (10.0) |
| Belgium | 174 | 2 |
1.1% (0.1–4.1%) |
2 (100.0) | 0 (0.0) |
| Denmark* | 215 | 73 |
34.0% (27.7–40.7%) |
66 (90.4) | 6 (8.2) |
| England | 172 | 94 |
54.7% (46.9–62.2%) |
89 (94.7) | 5 (5.3) |
| France | 699 | 170 |
24.3 (21.2–27.7%) |
124 (72.9) | 46 (27.1) |
| Germany* | 284 | 141 |
49.6% (43.7–55.6%) |
124 (87.9) | 15 (10.6) |
| Greece | 130 | 36 |
27.7% (20.2–36.2%) |
19 (52.8) | 17 (47.2) |
| Israel | 58 | 20 |
34.5% (22.5–48.1%) |
15 (75.0) | 5 (25.0) |
| Netherlands | 338 | 11 |
3.3% (1.6–5.8%) |
7 (63.6) | 4 (36.4) |
| Norway | 23 | 12 |
52.2% (30.6–73.2%) |
12 (100.0) | 0 (0.0) |
| Poland | 129 | 4 |
3.1% (0.9–7.8%) |
2 (50.0) | 2 (50.0) |
| Portugal | 91 | 48 |
52.7% (42.0–63.3%) |
39 (81.3) | 9 (18.7) |
| Spain* | 408 | 46 |
11.3% (8.4–14.8%) |
30 (66.0) | 15 (34.0) |
| Switzerland | 263 | 93 |
35.4% (29.6–41.5%) |
63 (67.7) | 30 (32.3) |
| Wales | 50 | 31 |
62.0% (47.2–75.4%) |
29 (93.5) | 2 (6.5) |
NIV—noninvasive ventilation
*Day of NIV initiation was unknown in 2 patients from Germany and 1 patient from Denmark and Spain